Comparison of Allogeneic Stem Cell Transplantation and Non-Transplant Approaches in Elderly Patients with Advanced Myelodysplastic Syndrome: Optimal Statistical Approaches and a Critical Appraisal of Clinical Results Using Non-Randomized Data
暂无分享,去创建一个
H. Putter | G. Mufti | N. Kröger | R. Brand | M. Robin | D. Niederwieser | U. Germing | G. Kobbe | A. Symeonidis | R. Martino | T. D. de Witte | M. Bornhäuser | J. Finke | A. van Biezen | L. Garderet | C. Schmid | F. Onida | M. van Gelder
[1] Hein Putter,et al. The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models , 2010, Comput. Methods Programs Biomed..
[2] G. Mufti,et al. Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Valeria Santini,et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. , 2009, The Lancet. Oncology.
[4] M. Maris,et al. Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] Harriet Noreen,et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. , 2007, Blood.
[6] H Putter,et al. Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.
[7] G. Mufti,et al. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. , 2006, Blood.
[8] J. Panse,et al. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS) , 2006, Bone Marrow Transplantation.
[9] Berthold Göttgens,et al. Genome-wide identification of cis-regulatory sequences controlling blood and endothelial development. , 2004, Human molecular genetics.
[10] N. Kröger,et al. Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning , 2005, Leukemia.
[11] G. Mufti,et al. Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning. , 2004, Blood.
[12] John P Klein,et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. , 2004, Blood.
[13] John P Klein,et al. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. , 2002, Blood.
[14] J. Sierra,et al. Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes. , 2002, Blood.
[15] H. Deeg,et al. Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. , 2002, Blood.
[16] G. Meloni,et al. Haematopoietic stem cell transplantation for patients with myelo‐dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) , 2000, British journal of haematology.
[17] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[18] Niels Keiding,et al. Random truncation models and Markov processes , 1990 .